Contact DMCA Privacy

Robuta

https://www.clinicaltrialsarena.com/news/tevogen-cell-therapy-covid/
Tevogen begins final dose level in trial of cell therapy for Covid-19
Tevogen Bio has commenced the final dose level in an open-label trial of its T cell therapy, TVGN-489, to treat Covid-19 patients.
final dosecell therapybeginsleveltrial